Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family
WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) […]
WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) […]
FREMONT, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) — Amprius Technologies, Inc. (“Amprius”)(NYSE: AMPX), a leader in next-generation lithium-ion batteries with […]
NEW YORK, NY, Aug. 13, 2024 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE: SAR) (“Saratoga Investment,” “Saratoga” or “the Company”) […]
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone […]
MACAU, Aug. 13, 2024 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a […]
HAMILTON, Ontario, Aug. 13, 2024 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a gift card, loyalty […]
TORONTO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to provide […]
– VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for metastatic Pancreatic Ductal Adenocarcinoma (PDAC), is […]
CHICAGO, Aug. 13, 2024 (GLOBE NEWSWIRE) — Auto insurance shopping volume set a new record for the second consecutive quarter, […]
Company plans to file its 2023 Annual Report on Form 10-K after market on August 13, 2024 Significant filing delays […]